Resistance testing debate: does it make the grade?
- PMID: 11366943
Resistance testing debate: does it make the grade?
Abstract
AIDS: An overview of genotypic and phenotypic drug-resistance assays, or tests, are described. Genotypic assays identify changes in the sequence of nucleotide bases in HIV by detecting amino acid substitutions. Genotypic tests can only discern mutations already identified by researchers, and must be conducted on individuals whose viral load is a minimum of 500 copies. More sensitive tests should be available by the end of 1999. Phenotypic tests assess the ability of HIV to replicate when exposed to particular drugs, and may help researchers identify the necessary quantity of a drug to halt reproduction. Also discussed are HIV subpopulations which are often not detected by the assays, and may be resistant to certain drugs. Two clinical trials are cited, GART (Genotypic Antiretroviral Resistance Testing) and VIRADAPT, which observed benefits from conducting genotypic testing. A glossary of terms used in the article is provided.
Similar articles
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
-
HIV resistance-testing information on web.AIDS Treat News. 2000 Feb 18;(No 337):6. AIDS Treat News. 2000. PMID: 11367209
-
Genotypic resistance tests for the clinical management of patients with primary HIV infection.Scand J Infect Dis Suppl. 2003;106:66-70. Scand J Infect Dis Suppl. 2003. PMID: 15000588 Review.
-
Geno- and phenotypic resistance tests.Proj Inf Perspect. 1998 Sep;(25):9-10. Proj Inf Perspect. 1998. PMID: 11365852
-
HIV-1 drug resistance assays in clinical management.AIDS Clin Care. 1998 Nov;10(11):81-5, 87-8. AIDS Clin Care. 1998. PMID: 11365861
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical